LM-364 alone or with other treatments for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called LM-364, either by itself or combined with other anti-cancer treatments. The goal is to see if it can help people with advanced solid tumors that have not responded to standard therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are willing to sign a consent form.
- You have a good performance status (able to take care of yourself and be up and about more than half of your waking hours).
- You have a life expectancy of at least 3 months.
- Your organs (like kidneys, liver, and bone marrow) are functioning well enough.
- You have not had another experimental treatment within the past 28 days.
- You have recovered from any side effects of previous cancer treatments (except for minor ones like hair loss).
- You do not have uncontrolled pain related to your tumor.
- You have not had a live vaccine in the past 28 days.
- You have not had major surgery in the past 28 days.
- You do not have severe heart disease.
- You do not have an autoimmune disease or a history of immunodeficiency.
- You do not have another active cancer that may need treatment.
- If you are able to get pregnant, you must not be pregnant or breastfeeding, and you agree to use birth control.
- You do not have a psychiatric condition that would prevent you from following the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called LM-350 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug can shrink tumors or slow their growth.
This Phase I/II study tests LM-101, a new injection, in adults with advanced solid cancers that have already been treated and kept growing. It aims to see how safe it is and whether it can shrink tumors or help people live longer.
This study tests a new drug called LM-299 for people with advanced solid tumors that haven't responded to standard treatments. The goal is to see if LM-299 is safe and effective.
This study tests a new drug called LM-168, either alone or with another immunotherapy (toripalimab), in people with advanced solid tumors that haven't responded to standard treatments. It aims to see if this combination is safe and effective, and may offer a new option when others have stopped working.
This study tests an investigational drug called LM-364, either by itself or combined with other cancer therapies, in people with advanced solid tumors. The goal is to see if the drug is safe and effective, and it may offer a new treatment option.
This trial tests a new drug called LM-168, either alone or combined with another cancer treatment, for people with advanced solid tumors that have not responded to standard therapies. The goal is to see if it can shrink tumors or slow their growth.
Hear when a new Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.